753 related articles for article (PubMed ID: 26091828)
1. APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity.
Swanton C; McGranahan N; Starrett GJ; Harris RS
Cancer Discov; 2015 Jul; 5(7):704-12. PubMed ID: 26091828
[TBL] [Abstract][Full Text] [Related]
2. Family-Wide Comparative Analysis of Cytidine and Methylcytidine Deamination by Eleven Human APOBEC Proteins.
Ito F; Fu Y; Kao SA; Yang H; Chen XS
J Mol Biol; 2017 Jun; 429(12):1787-1799. PubMed ID: 28479091
[TBL] [Abstract][Full Text] [Related]
3. Addressing the benefits of inhibiting APOBEC3-dependent mutagenesis in cancer.
Petljak M; Green AM; Maciejowski J; Weitzman MD
Nat Genet; 2022 Nov; 54(11):1599-1608. PubMed ID: 36280735
[TBL] [Abstract][Full Text] [Related]
4. Clinical Implications of APOBEC3-Mediated Mutagenesis in Breast Cancer.
Roelofs PA; Martens JWM; Harris RS; Span PN
Clin Cancer Res; 2023 May; 29(9):1658-1669. PubMed ID: 36478188
[TBL] [Abstract][Full Text] [Related]
5. Competition for DNA binding between the genome protector replication protein A and the genome modifying APOBEC3 single-stranded DNA deaminases.
Wong L; Sami A; Chelico L
Nucleic Acids Res; 2022 Nov; 50(21):12039-12057. PubMed ID: 36444883
[TBL] [Abstract][Full Text] [Related]
6. A portable hot spot recognition loop transfers sequence preferences from APOBEC family members to activation-induced cytidine deaminase.
Kohli RM; Abrams SR; Gajula KS; Maul RW; Gearhart PJ; Stivers JT
J Biol Chem; 2009 Aug; 284(34):22898-904. PubMed ID: 19561087
[TBL] [Abstract][Full Text] [Related]
7. APOBEC3 cytidine deaminases in double-strand DNA break repair and cancer promotion.
Nowarski R; Kotler M
Cancer Res; 2013 Jun; 73(12):3494-8. PubMed ID: 23598277
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo.
Beale RC; Petersen-Mahrt SK; Watt IN; Harris RS; Rada C; Neuberger MS
J Mol Biol; 2004 Mar; 337(3):585-96. PubMed ID: 15019779
[TBL] [Abstract][Full Text] [Related]
9. AID/APOBEC deaminases disfavor modified cytosines implicated in DNA demethylation.
Nabel CS; Jia H; Ye Y; Shen L; Goldschmidt HL; Stivers JT; Zhang Y; Kohli RM
Nat Chem Biol; 2012 Sep; 8(9):751-8. PubMed ID: 22772155
[TBL] [Abstract][Full Text] [Related]
10. Heat shock proteins stimulate APOBEC-3-mediated cytidine deamination in the hepatitis B virus.
Chen Z; Eggerman TL; Bocharov AV; Baranova IN; Vishnyakova TG; Kurlander R; Patterson AP
J Biol Chem; 2017 Aug; 292(32):13459-13479. PubMed ID: 28637869
[TBL] [Abstract][Full Text] [Related]
11. DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer.
Kanu N; Cerone MA; Goh G; Zalmas LP; Bartkova J; Dietzen M; McGranahan N; Rogers R; Law EK; Gromova I; Kschischo M; Walton MI; Rossanese OW; Bartek J; Harris RS; Venkatesan S; Swanton C
Genome Biol; 2016 Sep; 17(1):185. PubMed ID: 27634334
[TBL] [Abstract][Full Text] [Related]
12. APOBEC3-dependent kataegis and TREX1-driven chromothripsis during telomere crisis.
Maciejowski J; Chatzipli A; Dananberg A; Chu K; Toufektchan E; Klimczak LJ; Gordenin DA; Campbell PJ; de Lange T
Nat Genet; 2020 Sep; 52(9):884-890. PubMed ID: 32719516
[TBL] [Abstract][Full Text] [Related]
13. APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa.
Cho RJ; Alexandrov LB; den Breems NY; Atanasova VS; Farshchian M; Purdom E; Nguyen TN; Coarfa C; Rajapakshe K; Prisco M; Sahu J; Tassone P; Greenawalt EJ; Collisson EA; Wu W; Yao H; Su X; Guttmann-Gruber C; Hofbauer JP; Hashmi R; Fuentes I; Benz SC; Golovato J; Ehli EA; Davis CM; Davies GE; Covington KR; Murrell DF; Salas-Alanis JC; Palisson F; Bruckner AL; Robinson W; Has C; Bruckner-Tuderman L; Titeux M; Jonkman MF; Rashidghamat E; Lwin SM; Mellerio JE; McGrath JA; Bauer JW; Hovnanian A; Tsai KY; South AP
Sci Transl Med; 2018 Aug; 10(455):. PubMed ID: 30135250
[TBL] [Abstract][Full Text] [Related]
14. Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection.
Kim EY; Lorenzo-Redondo R; Little SJ; Chung YS; Phalora PK; Maljkovic Berry I; Archer J; Penugonda S; Fischer W; Richman DD; Bhattacharya T; Malim MH; Wolinsky SM
PLoS Pathog; 2014 Jul; 10(7):e1004281. PubMed ID: 25080100
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk between genetic and epigenetic information through cytosine deamination.
Chahwan R; Wontakal SN; Roa S
Trends Genet; 2010 Oct; 26(10):443-8. PubMed ID: 20800313
[TBL] [Abstract][Full Text] [Related]
16. APOBECs and Herpesviruses.
Cheng AZ; Moraes SN; Shaban NM; Fanunza E; Bierle CJ; Southern PJ; Bresnahan WA; Rice SA; Harris RS
Viruses; 2021 Feb; 13(3):. PubMed ID: 33671095
[TBL] [Abstract][Full Text] [Related]
17. APOBEC3-mediated mutagenesis in cancer: causes, clinical significance and therapeutic potential.
Butler K; Banday AR
J Hematol Oncol; 2023 Mar; 16(1):31. PubMed ID: 36978147
[TBL] [Abstract][Full Text] [Related]
18. APOBEC3 signature mutations in chronic lymphocytic leukemia.
Rebhandl S; Huemer M; Gassner FJ; Zaborsky N; Hebenstreit D; Catakovic K; Grössinger EM; Greil R; Geisberger R
Leukemia; 2014 Sep; 28(9):1929-32. PubMed ID: 24840555
[No Abstract] [Full Text] [Related]
19. APOBEC-mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development.
Henderson S; Chakravarthy A; Su X; Boshoff C; Fenton TR
Cell Rep; 2014 Jun; 7(6):1833-41. PubMed ID: 24910434
[TBL] [Abstract][Full Text] [Related]
20. APOBEC-induced mutations in human cancers are strongly enriched on the lagging DNA strand during replication.
Seplyarskiy VB; Soldatov RA; Popadin KY; Antonarakis SE; Bazykin GA; Nikolaev SI
Genome Res; 2016 Feb; 26(2):174-82. PubMed ID: 26755635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
